Kainos Medicine Inc (284620) - Total Liabilities

Latest as of June 2025: ₩4.18 Billion KRW ≈ $2.84 Million USD

Based on the latest financial reports, Kainos Medicine Inc (284620) has total liabilities worth ₩4.18 Billion KRW (≈ $2.84 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Kainos Medicine Inc - Total Liabilities Trend (2017–2024)

This chart illustrates how Kainos Medicine Inc's total liabilities have evolved over time, based on quarterly financial data. See 284620 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Kainos Medicine Inc Competitors by Total Liabilities

The table below lists competitors of Kainos Medicine Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Daesung Eltec Co. Ltd KQ:025440	Korea	₩292.76 Billion
Times Guaranty Limited NSE:TIMESGTY	India	Rs1.67 Million
Next Entertainment World Co. Ltd KQ:160550	Korea	₩116.80 Billion
Sin-Kung Logistics Berhad KLSE:0305	Malaysia	RM74.06 Million
Dragonfly Energy Holdings Corp. NASDAQ:DFLI	USA	$71.78 Million
Blue Star Gold Corp V:BAU	Canada	CA$3.08 Million
Canfor Pulp Products Inc. TO:CFX	Canada	CA$301.50 Million
Watos Corea Co. Ltd KQ:079000	Korea	₩4.35 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Kainos Medicine Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 284620 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.72	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.25	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kainos Medicine Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kainos Medicine Inc (2017–2024)

The table below shows the annual total liabilities of Kainos Medicine Inc from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩8.95 Billion ≈ $6.07 Million	-3.03%
2023-12-31	₩9.23 Billion ≈ $6.26 Million	-28.27%
2022-12-31	₩12.87 Billion ≈ $8.72 Million	-56.88%
2021-12-31	₩29.85 Billion ≈ $20.23 Million	+33.12%
2020-12-31	₩22.43 Billion ≈ $15.20 Million	+2739.13%
2019-12-31	₩789.89 Million ≈ $535.30K	+2.31%
2018-12-31	₩772.06 Million ≈ $523.21K	+4.31%
2017-12-31	₩740.19 Million ≈ $501.62K	--

About Kainos Medicine Inc

KQ:284620 Korea Biotechnology

Market Cap

$24.10 Million

₩35.56 Billion KRW

Market Cap Rank

#24534 Global

#1744 in Korea

Share Price

₩1087.00

Change (1 day)

-8.81%

52-Week Range

₩977.00 - ₩1270.00

All Time High

₩28151.21